157 related articles for article (PubMed ID: 36763157)
1. Alopecia areata in underrepresented groups: preliminary analysis of the all of us research program.
Moseley IH; George EA; Tran MM; Lee H; Qureshi AA; Cho E
Arch Dermatol Res; 2023 Aug; 315(6):1631-1637. PubMed ID: 36763157
[TBL] [Abstract][Full Text] [Related]
2. Onychomycosis in underrepresented groups: an all of us database analysis.
Moseley I; Ragi SD; Ouellette S; Rao B
Arch Dermatol Res; 2023 Apr; 315(3):647-651. PubMed ID: 36261664
[TBL] [Abstract][Full Text] [Related]
3. Trends in Prevalence and Incidence of Alopecia Areata, Alopecia Totalis, and Alopecia Universalis Among Adults and Children in a US Employer-Sponsored Insured Population.
Mostaghimi A; Gao W; Ray M; Bartolome L; Wang T; Carley C; Done N; Swallow E
JAMA Dermatol; 2023 Apr; 159(4):411-418. PubMed ID: 36857069
[TBL] [Abstract][Full Text] [Related]
4. Cardiovascular Health Disparities in Racial and Other Underrepresented Groups: Initial Results From the All of Us Research Program.
Acosta JN; Leasure AC; Both CP; Szejko N; Brown S; Torres-Lopez V; Abdelhakim S; Schindler J; Petersen N; Sansing L; Gill TM; Sheth KN; Falcone GJ
J Am Heart Assoc; 2021 Sep; 10(17):e021724. PubMed ID: 34431358
[TBL] [Abstract][Full Text] [Related]
5. Tinea pedis in underrepresented groups: All of Us database analysis.
Moseley I; Ragi SD; Ouellette S; Rao B
Mycoses; 2023 Jan; 66(1):29-34. PubMed ID: 35997514
[TBL] [Abstract][Full Text] [Related]
6. Overall and Racial and Ethnic Subgroup Prevalences of Alopecia Areata, Alopecia Totalis, and Alopecia Universalis.
Sy N; Mastacouris N; Strunk A; Garg A
JAMA Dermatol; 2023 Apr; 159(4):419-423. PubMed ID: 36857044
[TBL] [Abstract][Full Text] [Related]
7. Race and Alopecia Areata amongst US Women.
Thompson JM; Park MK; Qureshi AA; Cho E
J Investig Dermatol Symp Proc; 2018 Jan; 19(1):S47-S50. PubMed ID: 29273106
[TBL] [Abstract][Full Text] [Related]
8. Alopecia areata in Tunisia: epidemio-clinical aspects and comorbid conditions. A prospective study of 204 cases.
Arousse A; Boussofara L; Mokni S; Gammoudi R; Saidi W; Aounallah A; Belajouza C; Ghariani N; Denguezli M; Nouira R
Int J Dermatol; 2019 Jul; 58(7):811-815. PubMed ID: 30677128
[TBL] [Abstract][Full Text] [Related]
9. Familial implications of autoimmune disease: Recurrence risks of alopecia areata and associated conditions in first-degree relatives.
Agre K; McCarthy Veach P; Bemmels H; Wiens K; LeRoy BS; Hordinsky M
J Genet Couns; 2020 Feb; 29(1):35-43. PubMed ID: 31605426
[TBL] [Abstract][Full Text] [Related]
10. Comparing the burden of illness in patients with alopecia areata vs atopic dermatitis in the US population from a payer perspective.
Fenske DC; Ding Y; Morrow P; Smith SG; Silver MK; Moynihan M; Manjelievskaia J
J Manag Care Spec Pharm; 2023 Apr; 29(4):409-419. PubMed ID: 36989453
[No Abstract] [Full Text] [Related]
11. Alopecia areata and overt thyroid diseases: A nationwide population-based study.
Han TY; Lee JH; Noh TK; Choi MW; Yun JS; Lee KH; Bae JM
J Dermatol; 2018 Dec; 45(12):1411-1417. PubMed ID: 30222206
[TBL] [Abstract][Full Text] [Related]
12. Racial characteristics of alopecia areata in the United States.
Lee H; Jung SJ; Patel AB; Thompson JM; Qureshi A; Cho E
J Am Acad Dermatol; 2020 Oct; 83(4):1064-1070. PubMed ID: 31279016
[TBL] [Abstract][Full Text] [Related]
13. History of atopy or autoimmunity increases risk of alopecia areata.
Barahmani N; Schabath MB; Duvic M;
J Am Acad Dermatol; 2009 Oct; 61(4):581-91. PubMed ID: 19608295
[TBL] [Abstract][Full Text] [Related]
14. Time-Dependent Risk of Acute Myocardial Infarction in Patients With Alopecia Areata in Korea.
Shin JW; Kang T; Lee JS; Kang MJ; Huh CH; Kim MS; Kim HJ; Ahn HS
JAMA Dermatol; 2020 Jul; 156(7):763-771. PubMed ID: 32401269
[TBL] [Abstract][Full Text] [Related]
15. Epidemiological, clinical and economic burden of alopecia areata in Spain: a real-world retrospective study. The PETALO study.
Vañó-Galván S; Figueras-Nart I; Artime E; Díaz-Cerezo S; Núñez M; Iglesias C; Artés M; Huete T
Eur J Dermatol; 2024 Apr; 34(2):163-175. PubMed ID: 38907547
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the Prevalence and Incidence of Pediatric Alopecia Areata Using Electronic Health Record Data.
McKenzie PL; Maltenfort M; Bruckner AL; Gupta D; Harfmann KL; Hyde P; Forrest CB; Castelo-Soccio L
JAMA Dermatol; 2022 May; 158(5):547-551. PubMed ID: 35385065
[TBL] [Abstract][Full Text] [Related]
17. The risk of alopecia areata and other related autoimmune diseases in patients with sleep disorders: a Korean population-based retrospective cohort study.
Seo HM; Kim TL; Kim JS
Sleep; 2018 Sep; 41(9):. PubMed ID: 29955877
[TBL] [Abstract][Full Text] [Related]
18. Autoimmune, atopic, and mental health comorbid conditions associated with alopecia areata in the United States.
Huang KP; Mullangi S; Guo Y; Qureshi AA
JAMA Dermatol; 2013 Jul; 149(7):789-94. PubMed ID: 23700152
[TBL] [Abstract][Full Text] [Related]
19. The prevalence of systemic sclerosis is increased among patients with alopecia areata: a population-based study.
Kridin K; Tzur Bitan D; Comaneshter D; Cohen AD
Immunol Res; 2019 Oct; 67(4-5):368-372. PubMed ID: 31741238
[TBL] [Abstract][Full Text] [Related]
20. Is there an association between alopecia areata and systemic lupus erythematosus? A population-based study.
Kridin K; Shalom G; Comaneshter D; Cohen AD
Immunol Res; 2020 Feb; 68(1):1-6. PubMed ID: 31970630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
